Fempharma is a European, research-driven B2B pharmaceutical company founded in 2016 with a clear mission: to improve women’s health through science-based innovation, particularly in the fields of gynecology and urology.
To ensure a distinct presence in the U.S. market, we established Eazing Pharma as our dedicated U.S. brand.
Our company’s strength lies in its ability to bridge basic and clinical research, translating scientific discoveries into unique healthcare products for women. Our portfolio includes innovative, niche products supported by strong scientific data and compliant with the highest quality standards, including ISO 13485, GMP and ISO 22000.
Today, our products are available in 19 countries. All intellectual property is developed in-house, allowing us to offer proprietary products with extensive medical and scientific backing.
